296 related articles for article (PubMed ID: 18672212)
1. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.
O'Connor JP; Jackson A; Asselin MC; Buckley DL; Parker GJ; Jayson GC
Lancet Oncol; 2008 Aug; 9(8):766-76. PubMed ID: 18672212
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous PET-MRI in oncology: a solution looking for a problem?
Yankeelov TE; Peterson TE; Abramson RG; Izquierdo-Garcia D; Arlinghaus LR; Li X; Atuegwu NC; Catana C; Manning HC; Fayad ZA; Gore JC
Magn Reson Imaging; 2012 Nov; 30(9):1342-56. PubMed ID: 22795930
[TBL] [Abstract][Full Text] [Related]
3. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
[TBL] [Abstract][Full Text] [Related]
4. Imaging in clinical trials.
Murphy P; Koh DM
Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S74-82. PubMed ID: 20880784
[TBL] [Abstract][Full Text] [Related]
5. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive imaging for studying anti-angiogenic therapy effects.
Ehling J; Lammers T; Kiessling F
Thromb Haemost; 2013 Mar; 109(3):375-90. PubMed ID: 23407722
[TBL] [Abstract][Full Text] [Related]
7. Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.
Thompson G; Mills SJ; Coope DJ; O'Connor JP; Jackson A
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S127-44. PubMed ID: 22433824
[TBL] [Abstract][Full Text] [Related]
8. Imaging of tumor angiogenesis: functional or targeted?
Turkbey B; Kobayashi H; Ogawa M; Bernardo M; Choyke PL
AJR Am J Roentgenol; 2009 Aug; 193(2):304-13. PubMed ID: 19620425
[TBL] [Abstract][Full Text] [Related]
9. [Molecular imaging in cancer therapy].
Weber WA
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
[TBL] [Abstract][Full Text] [Related]
10. Renal imaging in patients requiring renal replacement therapy.
Cowie A
Semin Dial; 2002; 15(4):237-49. PubMed ID: 12191024
[TBL] [Abstract][Full Text] [Related]
11. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
Abramson RG; Mavi A; Cermik T; Basu S; Wehrli NE; Houseni M; Mishra S; Udupa J; Lakhani P; Maidment AD; Torigian DA; Alavi A
Semin Nucl Med; 2007 May; 37(3):146-53. PubMed ID: 17418148
[TBL] [Abstract][Full Text] [Related]
12. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.
Ingrisch M; Sourbron S
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):281-300. PubMed ID: 23563847
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
14. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
15. An outlook on future design of hybrid PET/MRI systems.
Zaidi H; Del Guerra A
Med Phys; 2011 Oct; 38(10):5667-89. PubMed ID: 21992383
[TBL] [Abstract][Full Text] [Related]
16. Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
Messiou C; Orton M; Ang JE; Collins DJ; Morgan VA; Mears D; Castellano I; Papadatos-Pastos D; Brunetto A; Tunariu N; Mann H; Tessier J; Young H; Ghiorghiu D; Marley S; Kaye SB; deBono JS; Leach MO; deSouza NM
Radiology; 2012 Nov; 265(2):426-36. PubMed ID: 22891356
[TBL] [Abstract][Full Text] [Related]
17. Promise and pitfalls of quantitative imaging in oncology clinical trials.
Kurland BF; Gerstner ER; Mountz JM; Schwartz LH; Ryan CW; Graham MM; Buatti JM; Fennessy FM; Eikman EA; Kumar V; Forster KM; Wahl RL; Lieberman FS
Magn Reson Imaging; 2012 Nov; 30(9):1301-12. PubMed ID: 22898682
[TBL] [Abstract][Full Text] [Related]
18. Quantum dots for tumor-targeted drug delivery and cell imaging.
Misra RD
Nanomedicine (Lond); 2008 Jun; 3(3):271-4. PubMed ID: 18510421
[No Abstract] [Full Text] [Related]
19. [Application of molecular imaging to chemotherapy].
Fan W; Zhi SF; Liu JL
Ai Zheng; 2006 Jan; 25(1):122-5. PubMed ID: 16405766
[TBL] [Abstract][Full Text] [Related]
20. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.
Brix G; Griebel J; Kiessling F; Wenz F
Eur J Nucl Med Mol Imaging; 2010 Aug; 37 Suppl 1():S30-51. PubMed ID: 20503049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
